drugset / Trial / NCT05670782
A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease
RandomizedSequentialDouble-blindTreatment
Summary
The goal of this study is to test KM-819 in halting or slowing the progression of Parkinson's disease. The study evaluates the safety and tolerability of multiple ascending doses of KM-819 in healthy older adults and participants with Parkinson's disease.
Timeline
- Start
- 2022-07-19
- Primary completion
- 2025-10-30
- Completion
- 2025-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KM-819 | Unknown | 200 mg | Oral |
| Subject | KM-819 | Unknown | 400 mg | Oral |
| Subject | KM-819 | Unknown | 600 mg | Oral |
| Subject | KM-819 | Unknown | 800 mg | Oral |